A Free-Wilson/Fujita-Ban analysis and prediction of the analgesic potency of some 3-hydroxy- and 3-methoxy-N-alkylmorphinan-6-one opioids

Journal of Medicinal Chemistry
1990.0

Abstract

Herein we describe a Free-Wilson/Fujita-Ban QSAR (quantitative structure-activity relationship) analysis of the analgesic potency of over 50 semisynthetic opioid narcotics. The 3-hydroxy- and 3-methoxy-N-alkylmorphinan-6-ones of B/C-cis and -trans stereochemistry include compounds exhibiting structural variation at five positions [N-methyl (C17), oxygen at C3, C4-C5 oxygen bridge, alkyl substituents at C7 and C8]. The pharmacological parameter correlated was the analgesic potency (-log ED50) exhibited on abdominal contractions produced by acetylcholine injection in mice. A satisfactory correlation was obtained only by assuming interdependent contributions of the substituents on C17 and O(C3), with which it was possible to explain 75% of the variance. Phenolic compounds (3-OH) behave somewhat differently from the methyl ethers (3-OCH3), and in both series the substituents on C8 have a size-dependent negative contribution, implying steric hindrance at their contact point on the receptor. With use of this correlation the potency of five further members of the series was predicted. Subsequent testing fully confirmed the validity of the correlation since the measured potencies were, within experimental error, equal to those calculated. In a further refinement, phenolic compounds were considered separately from the ethers, and it was found that the contribution of the substituents on C17, C7, and C8 remained similar in sign and magnitude but not that of the furan oxygen. This analysis allows us to conclude that if both phenolic and nonphenolic members of this series act on the same receptor they must bind at different subsites or in alternate modes, supporting an earlier proposal in the literature.

Knowledge Graph

Similar Paper

A Free-Wilson/Fujita-Ban analysis and prediction of the analgesic potency of some 3-hydroxy- and 3-methoxy-N-alkylmorphinan-6-one opioids
Journal of Medicinal Chemistry 1990.0
Probes for Narcotic Receptor Mediated Phenomena. 34. Synthesis and Structure−Activity Relationships of a Potent μ-Agonist δ-Antagonist and an Exceedingly Potent Antinociceptive in the Enantiomeric C9-Substituted 5-(3-Hydroxyphenyl)-N-phenylethylmorphan Series
Journal of Medicinal Chemistry 2007.0
Analgesic narcotic antagonists. 15. Potent narcotic agonist 7-.beta.-arylalkyl-4,5.alpha.-epoxymorphinans
Journal of Medicinal Chemistry 1983.0
Structure–activity relationships of some opiate glycosides
Bioorganic & Medicinal Chemistry Letters 2003.0
Quantum chemical studies of N-substituent variation in the oxymorphone series of opiate narcotics
Journal of Medicinal Chemistry 1978.0
Probes for narcotic receptor mediated phenomena. 48. C7- and C8-substituted 5-phenylmorphan opioids from diastereoselective alkylation
European Journal of Medicinal Chemistry 2013.0
Synthesis and analgetic activity of some 5-aryl-2-azabicyclo[3.2.1]octanes
Journal of Medicinal Chemistry 1978.0
Substituted 1-(aminomethyl)-2-(arylacetyl)-1,2,3,4-tetrahydroisoquinolines: a novel class of very potent antinociceptive agents with varying degrees of selectivity for .kappa. and .mu. opioid receptors
Journal of Medicinal Chemistry 1992.0
Synthesis and pharmacological activity of some N-alkyl-substituted 9.alpha.-ethyl-2'-hydroxy-5-methyl-6,7-benzomorphans
Journal of Medicinal Chemistry 1977.0
C-Alkylated spiro[benzofuran-3(2H),4′-1′-methyl-piperidine-7-ols] as potent opioids: A conformation-activity study
Bioorganic & Medicinal Chemistry Letters 1998.0